Zurcher Kantonalbank (Zurich Cantonalbank)
BankPosition in ABBV — AbbVie Inc.
CIK 1368163
ZURICH, V8
Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$237,815,653
+$94,146,979 QoQ
Shares Held
945,063
+43.1% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#138
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Zurcher Kantonalbank (Zurich Cantonalbank) holds $2,475,409,533 across 14 Drug Manufacturers - General names. ABBV ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
661,071 | $792,908,455 | |
| 2 | JNJ |
Johnson & Johnson
|
1,415,198 | $359,417,836 | |
| 3 | AZN |
Astrazeneca PLC
|
1,878,727 | $356,244,213 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
945,063 | $237,815,653 | |
| 5 | MRK |
Merck & Co., Inc.
|
1,482,295 | $190,474,907 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,107,162 | $139,878,847 | |
| 7 | BIIB |
Biogen Inc.
|
540,001 | $116,672,616 | |
| 8 | AMGN |
Amgen Inc
|
293,442 | $106,261,217 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $237,815,653 | 945,063 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $143,668,674 | 660,576 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $152,343,651 | 666,741 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $215,074,727 | 928,888 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $177,296,613 | 955,159 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $128,742,078 | 614,462 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $101,022,094 | 568,498 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $118,041,695 | 597,740 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $101,495,930 | 591,744 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $91,298,748 | 501,366 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $63,062,097 | 406,931 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $99,934,742 | 670,433 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $100,478,400 | 745,776 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $197,610,512 | 1,239,948 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $197,613,960 | 1,222,783 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $162,251,568 | 1,208,938 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $179,987,658 | 1,175,161 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $178,608,096 | 1,101,771 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $128,615,376 | 949,892 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $102,455,788 | 949,808 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $102,360,023 | 908,736 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $96,545,226 | 892,120 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $60,688,259 | 566,386 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $53,522,132 | 611,053 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $55,113,539 | 561,352 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $45,765,199 | 600,672 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||